Some developments in brain ageing and dementia
- PMID: 9499598
Some developments in brain ageing and dementia
Abstract
The aetiology of the common dementias of old age remains incompletely understood. Here we describe some of the biological, neurophysiological and psychological changes associated with ageing of the human brain, in terms of those that occur throughout life and those that are characteristic of senescence. Age-dependent diseases, such as Alzheimer's disease (AD), idiopathic Parkinson's disease (IPD) and dementia with Lewy bodies (DLB), are considered from these viewpoints, and risk factors described. Vascular dementia (VaD) is related to hypertension and atherosclerosis and detailed description of its pathogenesis is outside the scope of this review. The importance of age as the main risk factor raises basic questions about the relationship of these diseases to the ageing process itself. Similarities and differences between ageing and disease may be important for a rational approach to prevention and treatment of cognitive decline and dementia in later life.
Similar articles
-
Depression and dementia.J Neurol Sci. 2009 Aug 15;283(1-2):139-42. doi: 10.1016/j.jns.2009.02.346. Epub 2009 Apr 5. J Neurol Sci. 2009. PMID: 19345960 Review.
-
[Dementia with Lewy bodies].Neurologia. 2000 Jan;15(1):15-21. Neurologia. 2000. PMID: 10730062 Review. Spanish.
-
EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.Brain. 2008 Mar;131(Pt 3):690-705. doi: 10.1093/brain/awm322. Epub 2008 Jan 17. Brain. 2008. PMID: 18202105
-
MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.J Neurol Sci. 2007 Jun 15;257(1-2):97-104. doi: 10.1016/j.jns.2007.01.016. Epub 2007 Feb 21. J Neurol Sci. 2007. PMID: 17316690
-
Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease.Mov Disord. 2006 Mar;21(3):337-42. doi: 10.1002/mds.20726. Mov Disord. 2006. PMID: 16211595
Cited by
-
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2. Cochrane Database Syst Rev. 2021. PMID: 33704781 Free PMC article.
-
Galantamine for vascular cognitive impairment.Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD004746. doi: 10.1002/14651858.CD004746.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2006 Jan 25;(4):CD004746. doi: 10.1002/14651858.CD004746.pub2. PMID: 16437493 Free PMC article. Updated.
-
Rivastigmine for vascular cognitive impairment.Cochrane Database Syst Rev. 2013 May 31;2013(5):CD004744. doi: 10.1002/14651858.CD004744.pub3. Cochrane Database Syst Rev. 2013. PMID: 23728651 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical